Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DROSPIRENONE Cause Product dose omission in error? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Product dose omission in error have been filed in association with DROSPIRENONE (Angeliq). This represents 0.3% of all adverse event reports for DROSPIRENONE.

10
Reports of Product dose omission in error with DROSPIRENONE
0.3%
of all DROSPIRENONE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Product dose omission in error From DROSPIRENONE?

Of the 10 reports.

Is Product dose omission in error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DROSPIRENONE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does DROSPIRENONE Cause?

Intermenstrual bleeding (1,086) Amenorrhoea (603) Heavy menstrual bleeding (436) Dysmenorrhoea (240) Product use in unapproved indication (154) Intentional dose omission (123) Nausea (118) Headache (117) Menstruation irregular (117) Product dose omission issue (116)

What Other Drugs Cause Product dose omission in error?

DUPILUMAB (7,586) TOFACITINIB (2,461) LENALIDOMIDE (618) PALBOCICLIB (592) DIROXIMEL (481) ABALOPARATIDE (457) NIRAPARIB (428) RUXOLITINIB (425) TERIFLUNOMIDE (371) DIMETHYL (308)

Which DROSPIRENONE Alternatives Have Lower Product dose omission in error Risk?

DROSPIRENONE vs DROSPIRENONE\ESTETROL DROSPIRENONE vs DROSPIRENONE\ESTRADIOL DROSPIRENONE vs DROSPIRENONE\ETHINYL ESTRADIOL DROSPIRENONE vs DROSPIRENONE\ETHINYL ESTRADIOL\LEVOMEFOLATE DROSPIRENONE vs DROTAVERINE

Related Pages

DROSPIRENONE Full Profile All Product dose omission in error Reports All Drugs Causing Product dose omission in error DROSPIRENONE Demographics